Rapid molecular testing helps to meet the diagnostic challenges of respiratory infections and minimize the spread of antimicrobial resistance

This case study highlights how rapid molecular diagnostic testing can support earlier detection of respiratory infections and antimicrobial resistance, helping to improve infection control, antimicrobial stewardship, and patient outcomes. Drawing on real‑world experience from UK healthcare settings, including outbreak response and decentralized testing models, the resource illustrates how timely PCR‑based diagnostics can reduce transmission, strengthen clinical decision‑making, and support delivery of the UK antimicrobial resistance national action plan.